31 May Multitarget new drugs derived carbonyl-indazolyl 1
Posted at 13:17h
in transferencia
[one_fourth]
[/one_fourth][three_fourth_last][box]The CSIC, Rey Juan Carlos University and the Hospital de Alcorcón carbonílicos have developed new derivatives of 1-indazolyl cannabinoid drugs as multitarget properties and / or cholinergic and / or regulators of beta-amyloid pétido. These compounds may serve for both for treatment and prevention of diseases and regulated by said systems, primarily for the treatment of Alzheimer’s disease disorders.[/box]
Download Leaflet
[/three_fourth_last]